WHO ICTRP trial
SAFIRE: Safety of Antimalarials in the FIRst Trimester
PACTR202505891635396 · Pan African Clinical Trials Registry (PACTR) · Recruiting
Key facts
| Trial ID | PACTR202505891635396 |
|---|---|
| Public title | SAFIRE: Safety of Antimalarials in the FIRst Trimester |
| Scientific title | A multicentre open-label, non-inferiority adaptive platform randomised controlled trial to evaluate the efficacy, safety, and tolerability of antimalarials for the treatment of uncomplicated malaria in the first trimester of pregnancy: Master protocol |
| Primary sponsor | Liverpool School of Tropical Medicine |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase-3 |
| Countries | Burkina Faso;Kenya;Mali |
| Conditions | Malaria;Malaria |
| Interventions | Dihydroartemisinin piperaquine ;Pyronaridine artesunate;Artemether lumefantrine |
| Registration date | May 19, 2025 |
| Target size | 1510 |
| Secondary IDs | 24036;MMVSAFIRE2401;5355146 ;202501003;2024312CEUSTTB |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: